483
Schwabe North America, Inc.FDA 483 - Schwabe North America, Inc. - August 28, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Schwabe North America, Inc. in Green Bay, WI, revealed significant deficiencies in their quality control system. The firm failed to thoroughly investigate unexplained discrepancies and deviations during the manufacturing of homeopathic drug products. This included a lack of comprehensive root cause analysis, product impact assessments, proper documentation, and corrective actions, indicating potential systemic issues.
Open in Dashboard
ID · d318bbaf-9144-490d-a9bf-4862e8c9964c